MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 1 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28 | -47.2% | 214,337 | +46.7% | 0.00% | – |
Q2 2023 | $53 | -34.6% | 146,100 | -15.0% | 0.00% | – |
Q1 2023 | $81 | +32.8% | 171,929 | +42.0% | 0.00% | – |
Q4 2022 | $61 | -99.7% | 121,096 | +258.3% | 0.00% | – |
Q3 2022 | $21,000 | -95.6% | 33,800 | -94.5% | 0.00% | -100.0% |
Q2 2021 | $472,000 | +221.1% | 609,152 | +333.9% | 0.00% | – |
Q1 2021 | $147,000 | -91.1% | 140,403 | -88.5% | 0.00% | -100.0% |
Q4 2020 | $1,658,000 | +704.9% | 1,219,162 | +356.6% | 0.00% | – |
Q2 2020 | $206,000 | -66.5% | 267,000 | -73.9% | 0.00% | -100.0% |
Q1 2020 | $615,000 | -9.0% | 1,024,300 | +243.8% | 0.00% | 0.0% |
Q4 2019 | $676,000 | +144.9% | 297,942 | +17.8% | 0.00% | – |
Q1 2019 | $276,000 | +122.6% | 253,000 | +87.5% | 0.00% | – |
Q3 2018 | $124,000 | +785.7% | 134,900 | +325.6% | 0.00% | – |
Q2 2018 | $14,000 | – | 31,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |